Variant report
Variant | esv3523741 |
---|---|
Chromosome Location | chr14:70888699-70893997 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EBF1 | chr14:70892166-70892349 | GM12878 | blood: | n/a | n/a |
2 | GATA3 | chr14:70888909-70889286 | T-47D | breast: | n/a | n/a |
3 | GATA3 | chr14:70892092-70892386 | T-47D | breast: | n/a | n/a |
4 | NFIC | chr14:70892067-70892489 | ECC-1 | luminal epithelium: | n/a | n/a |
5 | POLR2A | chr14:70891142-70891186 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr14:70891190-70891206 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr14:70893251-70893336 | ProgFib | skin: | n/a | n/a |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ADAM20-1 | chr14:70892529-70892807 | ENSG00000257759 |
2 | lnc-ADAM20-1 | chr14:70892691-70892807 | XLOC_011061 |
3 | lnc-ADAM20-1 | chr14:70892663-70892807 | XLOC_011061 |
No data |
No data |
Variant related genes | Relation type |
---|---|
SYNJ2BP | TF binding region |
SYNJ2BP-COX16 | TF binding region |
PANK3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28645155 | chr14:70888717-70888718 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs139950364 | chr14:70888738-70888739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537824740 | chr14:70888795-70888796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145958066 | chr14:70888801-70888802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555918805 | chr14:70888830-70888831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185583012 | chr14:70888832-70888833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188184765 | chr14:70888900-70888901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545735717 | chr14:70888921-70888922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553513565 | chr14:70888932-70888933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368133205 | chr14:70888935-70888936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371660891 | chr14:70888964-70888965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545753598 | chr14:70888966-70888967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564385758 | chr14:70888974-70888975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114815527 | chr14:70888996-70888997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546368229 | chr14:70889002-70889003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73291907 | chr14:70889098-70889099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542599978 | chr14:70889115-70889116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74517201 | chr14:70889149-70889150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548711000 | chr14:70889196-70889197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560633980 | chr14:70889197-70889198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527907718 | chr14:70889252-70889253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61979077 | chr14:70889281-70889282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs2332376 | chr14:70889285-70889286 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs185650523 | chr14:70889286-70889287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61979078 | chr14:70889303-70889304 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs567719207 | chr14:70889318-70889319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113047744 | chr14:70889380-70889381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535146765 | chr14:70889399-70889400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553474900 | chr14:70889404-70889405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143591229 | chr14:70889415-70889416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146316126 | chr14:70889487-70889488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148505226 | chr14:70889504-70889505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576283856 | chr14:70889505-70889506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12589762 | chr14:70889546-70889547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs190415225 | chr14:70889565-70889566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181593971 | chr14:70889664-70889665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562426179 | chr14:70889762-70889763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377248537 | chr14:70889784-70889785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542313697 | chr14:70889806-70889807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186784449 | chr14:70889930-70889931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs527814528 | chr14:70889976-70889977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546367206 | chr14:70889989-70889990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564569029 | chr14:70890098-70890099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372011160 | chr14:70890113-70890114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12586722 | chr14:70890140-70890141 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs550080132 | chr14:70890169-70890170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191619174 | chr14:70890178-70890179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs151056714 | chr14:70890179-70890180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs8008210 | chr14:70890188-70890189 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs565759711 | chr14:70890198-70890199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
cataract | 16735990 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:70884000-70889000 | Weak transcription | Fetal Muscle Leg | muscle |
2 | chr14:70888600-70889800 | Enhancers | HSMM | muscle |
3 | chr14:70888800-70889800 | Enhancers | HSMMtube | muscle |
4 | chr14:70889000-70890000 | Enhancers | Fetal Muscle Leg | muscle |
5 | chr14:70889800-70890600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr14:70890600-70892600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr14:70892000-70893000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr14:70892200-70892600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
9 | chr14:70892200-70892800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr14:70892200-70892800 | Enhancers | Psoas Muscle | Psoas |
11 | chr14:70892400-70892800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr14:70892400-70892800 | Enhancers | Skeletal Muscle Female | skeletal muscle |